Tara Gomes


Scientist, Li Ka Shing Knowledge Institute


Dr. Tara Gomes is an epidemiologist and Principal Investigator of the Ontario Drug Policy Research Network (ODPRN), a provincial network of researchers with expertise in pharmaceutical utilization, outcomes and policy who rapidly conduct research for drug decision-makers in Ontario and across Canada.  She is also a Scientist in the Li Ka Shing Knowledge Institute of St. Michael’s Hospital and the Institute for Clinical Evaluative Sciences and an assistant professor at the University of Toronto.  Her research is focused on pharmacoepidemiology, drug safety and drug policy research leveraging large, administrative databases, and she has published over 125 peer-reviewed articles and over 50 policy reports in this area.

Dr. Gomes has worked closely with the Ontario Ministry of Health and Long-Term Care and the Canadian Network for Observational Drug Effect Studies (CNODES) to develop evidence to inform policies related to opioid use and abuse in Ontario and more broadly across Canada.  She has also served as an expert for the US Food and Drug Administration and the US Department of Transportation in discussions related to opioid policies and regulations. In 2014, the ODPRN was awarded the Institute for Public Administration of Canada’s Bronze Public Sector Leadership Award in Health and Education.

Recent Publications

  1. Tadrous, M, Khuu, W, Lebovic, G, Stanbrook, MB, Martins, D, Paterson, JM et al.. Real-world health care utilization and effectiveness of omalizumab for the treatment of severe asthma. Ann. Allergy Asthma Immunol. 2017; :. doi: 10.1016/j.anai.2017.08.016. PubMed PMID:28986124 .
  2. Gomes, T, Juurlink, DN, Antoniou, T, Mamdani, MM, Paterson, JM, van den Brink, W et al.. Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case-control study. PLoS Med. 2017;14 (10):e1002396. doi: 10.1371/journal.pmed.1002396. PubMed PMID:28972983 PubMed Central PMC5626029.
  3. Gomes, T, Juurlink, DN, Mamdani, MM, Paterson, JM, van den Brink, W. Prevalence and characteristics of opioid-related deaths involving alcohol in Ontario, Canada. Drug Alcohol Depend. 2017;179 :416-423. doi: 10.1016/j.drugalcdep.2017.07.008. PubMed PMID:28867560 .
  4. Lunsky, Y, Khuu, W, Tadrous, M, Vigod, S, Cobigo, V, Gomes, T et al.. Antipsychotic Use With and Without Comorbid Psychiatric Diagnosis Among Adults with Intellectual and Developmental Disabilities. Can J Psychiatry. 2017; :706743717727240. doi: 10.1177/0706743717727240. PubMed PMID:28830241 .
  5. Vigod, SN, Gomes, T, Ray, JG. Prenatal Antidepressant Use and Autism Spectrum Disorder-Reply. JAMA. 2017;318 (7):665. doi: 10.1001/jama.2017.8643. PubMed PMID:28810018 .
  6. Guan, Q, Khuu, W, Spithoff, S, Kiran, T, Kahan, M, Tadrous, M et al.. Patterns of physician prescribing for opioid maintenance treatment in Ontario, Canada in 2014. Drug Alcohol Depend. 2017;177 :315-321. doi: 10.1016/j.drugalcdep.2017.05.002. PubMed PMID:28733101 .
  7. Ho, JM, Macdonald, EM, Luo, J, Gomes, T, Antoniou, T, Mamdani, MM et al.. Pregabalin and heart failure: A population-based study. Pharmacoepidemiol Drug Saf. 2017;26 (9):1087-1092. doi: 10.1002/pds.4239. PubMed PMID:28620909 .
  8. Persaud, N, Lee, T, Ahmad, H, Li, W, Taglione, MS, Rajakulasingam, Y et al.. Protocol for a randomised controlled trial evaluating the effects of providing essential medicines at no charge: the Carefully seLected and Easily Accessible at No Charge Medicines (CLEAN Meds) trial. BMJ Open. 2017;7 (5):e015686. doi: 10.1136/bmjopen-2016-015686. PubMed PMID:28611089 PubMed Central PMC5623428.
  9. Gomes, T, Shah, BR, Mamdani, MM. More Rigorous Study Needed Before Claiming No Harm of Blood Glucose Test Strip Limits for Patients Using Insulin-Reply. JAMA Intern Med. 2017;177 (6):890-891. doi: 10.1001/jamainternmed.2017.1089. PubMed PMID:28586809 .
  10. Spithoff, S, Turner, S, Gomes, T, Martins, D, Singh, S. First-line medications for alcohol use disorders among public drug plan beneficiaries in Ontario. Can Fam Physician. 2017;63 (5):e277-e283. . PubMed PMID:28500210 PubMed Central PMC5429069.
Search PubMed

Affiliations & Other Activities

  • Assistant Professor, Leslie Dan Faculty of Pharmacy, University of Toronto
  • Assistant Professor, Institute for Health Policy, Management and Evaluation, University of Toronto
  • Scientist, Institute for Clinical Evaluative Sciences
  • Principal Investigator, Ontario Drug Policy Research Network